Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Craig McNeill who wrote (981)	6/2/1998 1:03:00 PM
From: John L.	Read Replies (2) of 1432

Baxter stopping there blood substitute trials should be good news for Hextend since there will be less competition in the market right? It sounds like they had problems using there product in severe trauma cases which is the area Hextend wants. I hope this is a sign that others see Hextend as a superior product that they can't be competitive against. When can we expect to see the stock price start moving up again? Patience may be a virtue , but profits are sure more satisfying.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next